Table 1. Baseline clinical characteristics of study groups.
AMH—anti-Müllerian hormone, BMI—body mass index, E2—estradiol, FSH—follicle-stimulating hormone, IU—international unit, IVF—in vitro fertilization, LH—luteinizing hormone.
| Characteristic | Group 1 without genetic data Mean ± SD | Group 2 with genetic data Mean ± SD |
|---|---|---|
| No. of women | 5,779 | 264 |
| No. of IVF processes | 8,574 | 516 |
| Woman’s age (years) | 34.51 ± 4.54 | 34.55 ± 4.20 |
| BMI (kg/m2) | 23.42 ± 4.62 | 23.15 ± 4.11 |
| Stimulation days | 8.79 ± 4.36 | 9.77 ± 3.10 |
| FSH (mIU/mL) | 6.46 ± 2.83 | 7.25 ± 3.53 |
| LH (mIU/mL) | 6.23 ± 4.63 | 6.10 ± 4.63 |
| E2 (pg/mL) | 18.62 ± 18.50 | 16.62 ± 16.73 |
| AMH (ng/mL)a | 2.98 ± 2.42 | 3.38 ± 3.67 |
| No. of follicles (≤ 10 mm) on the first day of stimulation | 14.63 ± 8.99 | 13.41 ± 10.24 |
| No. of cumulus-denuded oocytes retrieved in previous stimulation | 8.26 ± 5.26 | 7.55 ± 6.15 |
| No. of MII oocytes retrieved in previous stimulation | 6.17 ± 4.10 | 5.85 ± 4.59 |
| No. of cumulus-denuded oocytes retrieved | 9.14 ± 5.82 | 7.67 ± 6.08 |
| No. of MII oocytes retrieved | 6.96 ± 4.64 | 5.92 ± 4.75 |
| Cumulative gonadotropin dose (IU) | 2,109.76 ± 826.62 | 2,347.36 ± 795.42 |
a) observations with an AMH level above 15ng/mL were removed from the database.